Government Spending Bill Extends Deadline for Filing COVID-19 Injury Claims
A new U.S. government spending bill will extend the time for those injured by the COVID-19 shot to file for federal vaccine injury compensation under the Countermeasures Injury Compensation Program (CICP). Under the bill, certain claimants previously denied compensation will be permitted to refile their claims. under the bill, as well. The continuing resolution bill […]
Russia Develops mRNA Cancer Biologic
Russia’s Ministry of Health announced last week that it has developed an mRNA (messenger ribonucleic acid) therapeutic biologic for cancer. A name for the shot has not yet been revealed, but it will cost the government about 300,000 rubles per dose—the equivalent of $2,869. The mRNA cancer biologic will be made available to the public […]
FDA Ordered to Release Data on Emergency Use Authorization of COVID-19 Shots
The U.S. Food and Drug Administration (FDA) has been ordered to disclose data it relied on when authorizing COVID-19 shots. U.S. District Court Judge Mark Pittman in Fort Worth, Texas ordered the FDA to release their file on “emergency use authorization” (EUA) related to the Pfizer/BioNTech Comirnaty COVID biologic to a group of scientists. Accordingly, […]
COVID Shots Injury Claims May Take Up to a Decade to Settle
A recent report released by the Select Subcommittee on the Coronavirus Pandemic Committee on Oversight and Accountability by the U.S. House of Representatives on Dec. 4, 2024 revealed that the Countermeasures Injury Compensation Program (CICP) is deeply flawed. Unless the system is drastically overhauled, it may take up to 10 years to process the existing […]
U.S. Government Extends Liability Shield for COVID Shot Makers
On Dec. 10, 2024, the U.S. Department of Health and Human Services (HSS) announced it would extend through Dec. 31, 2029 liability protections for pharmaceutical companies that produce COVID-19 biologics. According to Bloomberg Law, the liability shield also protects “health professionals prescribing, dispensing or administering vaccines, including state-licensed pharmacists, pharmacy technicians and pharmacy interns.” The […]
Recall of Clonazepam Anxiety Drug After Potential Life-Threatening Labeling Error
A voluntary recall in the United States has been issued for clonazepam (the generic name for Klonopin), an anxiety-reducing drug, due to a potentially fatal labeling mistake. The recall involves 16 lots of clonazepam Orally Disintegrating Tablets, which were found to be mislabeled with incorrect strengths and National Drug Code (NDC) numbers. The Pennsylvania-based pharmaceutical […]